Recombinant Anti-TAA Antibody (V3S-0622-YC61) (CAT#: V3S-0622-YC61)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a chimeric monoclonal antibody specific for a human carcinoma-associated protein antigen. The antigen has been found to be associated with colon cancer and certain breast and ovarian epithelial tissues. It has proved that mAb 31.1 inhibited tumor growth in vivo and inhibited the growth of both LS 174-T and ASPC-1 tumor cells in mice.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG1 kappa

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; FC; IHC; WB
Application Notes The antibody is recommended for detection of TAA by ELISA, FC, IHC (1/20-1/200), WB (1/1000-1/5000) assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target TAA
Alternative Name Carcinoma-associated antigen
Research Area Cancer Research
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry